Tag: Glucagon like peptide 1

According to the European Medicines Agency, non-arteritic anterior ischemic optic neuropathy (NAION) is a "very rare" side effect of semaglutide medicines, including Ozempic. While this association has been noted, particularly following recent studies, the absolute risk for individuals remains extremely low.

The human body releases a natural gut hormone, glucagon-like peptide-1 (GLP-1), within minutes of food ingestion to help regulate blood sugar and appetite. Understanding what is GLP-1 also known as is essential for grasping the mechanism behind a powerful class of modern medications used for treating type 2 diabetes and obesity.